Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma.
Nathalie S M LakLieke M J van ZogchelLily Zappeij-KannengieterAhmad JavadiRuben Van PaemelCharlotte VandeputteKatleen De PreterBram De WildeMathieu ChicardYasmine IddirGudrun SchleiermacherOlivia RuhenJanet M ShipleyMarta FioccoJohannes Hendrikus Maria MerksMax M Van NoeselC Ellen van der SchootGodelieve A M TytgatJanine StutterheimPublished in: JCO precision oncology (2023)
M in plasma at initial diagnosis correlated significantly with outcome, particularly when combined with paired analysis of blood and bone marrow using a rhabdomyosarcoma-specific RNA panel.